HEMATOPOIETIC STEM CELL TRANSPLANTATION
Clinical trials for HEMATOPOIETIC STEM CELL TRANSPLANTATION explained in plain language.
Never miss a new study
Get alerted when new HEMATOPOIETIC STEM CELL TRANSPLANTATION trials appear
Sign up with your email to follow new studies for HEMATOPOIETIC STEM CELL TRANSPLANTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a bone drug shield kids from fractures after transplant?
Disease control Recruiting nowThis early study tests whether giving zoledronate soon after a stem cell transplant can safely prevent bone loss and fractures in children. About 20 children aged 5 to 18 who are at high risk for bone problems will take part. The goal is to see if the drug is safe and easy to use…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: PHASE1 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC
-
New hope for bleeding risk after stem cell transplants
Disease control Recruiting nowThis study tests whether etamsylate, a drug that helps blood clot, can prevent serious bleeding in people who have low platelet counts after a stem cell transplant. About 404 adults aged 18 to 70 will receive either etamsylate or a placebo, and researchers will track bleeding eve…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: PHASE3 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
Could a donor stem cell transplant stop VEXAS syndrome?
Disease control Recruiting nowThis study tests whether a stem cell transplant from a healthy donor can control or reverse VEXAS syndrome, a rare and severe autoinflammatory disease. About 54 adults aged 18-75 whose standard treatments have failed will receive donor stem cells after chemotherapy and possibly r…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 12, 2026 12:07 UTC
-
Could a lower drug dose after stem cell transplants be safer and just as effective?
Disease control Recruiting nowThis study is for people with blood cancers like leukemia or lymphoma who need a stem cell transplant from a donor. After transplant, a drug called cyclophosphamide is given to prevent graft-versus-host disease, a serious side effect. Researchers want to find the lowest effective…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 09, 2026 12:07 UTC
-
New hope for leukemia patients: targeted drug aims to wipe out hidden cancer cells after transplant
Disease control Recruiting nowThis study tests a drug called inotuzumab ozogamicin in people with acute lymphoblastic leukemia (ALL) who have minimal residual disease (MRD) after a stem cell transplant. MRD means a few cancer cells remain that can cause a relapse. The goal is to see if the drug can clear thes…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: PHASE2 • Sponsor: Sheng-Li Xue, MD • Aim: Disease control
Last updated Jun 08, 2026 13:10 UTC
-
New drug aims to stop transplant rejection in High-Risk patients
Disease control Recruiting nowThis early-stage study tests whether a drug called emapalumab can prevent the body from rejecting a stem cell transplant. The study will include 20 patients who are at high risk for rejection. Researchers will also study how the drug works in the body to improve future treatments…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: EARLY_PHASE1 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Jun 01, 2026 17:57 UTC
-
Immune-Guided drug timing could cut CMV prevention after transplant
Prevention Recruiting nowThis study tests a personalized approach to stopping the drug Letermovir, which prevents a common virus called CMV after a stem cell transplant. Instead of giving the drug for a fixed 100 days, doctors will use a blood test to see when a patient's own immune system has recovered …
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: PHASE4 • Sponsor: WeiShi • Aim: Prevention
Last updated Jun 16, 2026 21:03 UTC
-
New cell therapy aims to prevent painful mouth sores in stem cell transplants
Prevention Recruiting nowThis study tests a single infusion of amimestrocel, made from umbilical cord cells, to prevent severe mouth and gut sores in 22 adults getting a stem cell transplant. The treatment is given 1-2 days before the transplant to reduce inflammation and promote healing. Researchers wil…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Prevention
Last updated Jun 15, 2026 19:07 UTC
-
Ancient heat therapy may shield transplant patients from painful bladder complication
Prevention Recruiting nowThis study tests whether moxibustion, a traditional therapy that burns herbs near the skin, can prevent hemorrhagic cystitis (painful bladder bleeding) in people who have received a stem cell transplant for blood cancers or severe aplastic anemia. About 266 participants will be r…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: NA • Sponsor: Yi Zhang • Aim: Prevention
Last updated Jun 15, 2026 19:03 UTC
-
Yoga may ease depression in stem cell transplant patients
Symptom relief Recruiting nowThis study aims to develop and test a yoga program that is adapted to different cultures for cancer patients who are in the hospital for a stem cell transplant. About 60 adults from India, Tanzania, and the United States will take part. The main goal is to see if the program help…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 16, 2026 20:50 UTC
-
Virtual buddy may ease transplant anxiety
Symptom relief Recruiting nowThis study tests whether a friendly digital avatar can help reduce anxiety and improve quality of life for people getting a stem cell transplant as an outpatient. About 90 adults will be randomly assigned to use the avatar program or receive usual care. The goal is to make the tr…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: NA • Sponsor: Victor Wang • Aim: Symptom relief
Last updated Jun 16, 2026 12:54 UTC
-
New program aims to ease Return-to-Work struggles after stem cell transplant
Symptom relief Recruiting nowThis study tests a new support program called WorkS for people who have had a stem cell transplant and are worried about going back to work. About 35 participants will try the program to see if it is helpful and easy to use. The goal is to improve confidence, work status, quality…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: NA • Sponsor: MGH Institute of Health Professions • Aim: Symptom relief
Last updated Jun 15, 2026 18:57 UTC
-
Massive study tracks heart risks in 10,000 stem cell survivors
Knowledge-focused Recruiting nowThis study follows 10,000 people who have had a stem cell transplant to learn about heart problems that may happen later. Researchers will collect health information and track events like heart attacks, strokes, and heart failure. The goal is to better understand and manage these…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Sponsor: Peking University People's Hospital • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:07 UTC
-
Can what you eat after a stem cell transplant change your outcome?
Knowledge-focused Recruiting nowThis study tracks 200 patients who have had a stem cell transplant to understand their nutritional health. Researchers measure body composition, food intake, and blood protein levels over six months. The goal is to see if better nutrition leads to longer survival and fewer compli…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Sponsor: The First Affiliated Hospital of Soochow University • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:02 UTC
-
Can planning ahead ease the stress of stem cell transplants for young adults?
Knowledge-focused Recruiting nowThis study looks at whether having guided conversations about care preferences helps young adults (ages 18-39) who are about to receive a stem cell transplant, along with their caregivers. Participants will fill out questionnaires and have three talks with a study team member ove…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: NA • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:57 UTC
-
Scientists track stem cell transplants for years to unlock secrets
Knowledge-focused Recruiting nowThis study follows people who have had a stem cell transplant (and their donors) for many years after the procedure. Researchers want to understand the long-term effects, how the transplanted cells change, and how to better fight cancer. Participants include adults and children w…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:56 UTC
-
New study tracks hidden senses after stem cell transplants
Knowledge-focused Recruiting nowThis study follows 70 leukemia patients receiving their first stem cell transplant to see how it changes their sense of smell, taste, and mouth feelings like cooling or burning. Researchers will test these senses and use brain scans to look for changes. The goal is to understand …
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Sponsor: University of Oslo • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:55 UTC
-
New genetic test could spot hidden infections in transplant patients
Knowledge-focused Recruiting nowThis study tests a new genetic method (metagenomic sequencing) to find bacteria, viruses, fungi, or parasites in the blood of people who have had a stem cell transplant. About 30 participants will give blood samples before and up to 6 months after transplant. The goal is to see i…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION
Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Knowledge-focused
Last updated May 27, 2026 11:50 UTC